In addition to product innovation and increasing adoption, the Spine Enabling Technology market is rapidly evolving due to mergers and acquisitions.

The Q123 WW Spine Enabling Tech Market was up +12.6% YoY, according to SmartTRAK Financial Dashboard. Medtronic (MDT) remained the market leader with 54.9% share, followed by Globus Medical (GMED) and other enabling tech competitors like Brainlab and Stryker (SYK). For detailed Q123 revenues and shares by company in the US, EU and ROW, see SmartTRAK Spine Enabling Tech Financial Dashboard*.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 US Spine Enabling Technology Market Recap* are:

• Complete Q123 Spine Enabling Tech Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Companies' News, Revenues, Data, Charts and Market Shares
• Mergers and Acquisitions Changing the Spine Enabling Technology Landscape
• New Spine Robots on the Horizon
• Milestones in Augmented Reality
• Q123 Regulatory Highlights

In February 2023, GMED announced it entered into a definitive agreement to combine in an all-stock transaction with NuVasive (NUVA). The transaction is expected to close mid-2023 subject to shareholder and regulatory agency approvals, which will make the combined company the ...

Read the entire Q123 Spine Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 US Orthobio Market Recap* are:

• Complete Q123 Orthobio Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Orthobio Companies' News, Revenues, Data, Charts and Market Shares
• US Bone Replacement – Springing Back Into Light
  • Growth Factors/Peptides
  • DBM and Synthetics
• US Cartilage Replacement –The Light Continues To Shine Bright
  • Cellular Grafts
  • Osteochondral Grafts
• US Soft Tissue Replacement – Sunny Days Continue
  • Soft Tissue Patches
  • Tendon Allografts
• US Meniscus Replacement – Sun is Shining Back on The Market

Despite continued healthcare staffing shortages and economic uncertainties, the US Bone Replacement experienced high single-digit percentage growth in Q123 as it benefited from increased utilization, especially in ...

Read the entire Q123 US Orthobio Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

This SAWC Spring 2023 perspective article extensively covers a wide range of topics pertaining to skin substitutes and Cellular and Tissue-based Products (CTPs), offering in-depth insights and analysis, and highlights a multitude of areas for discussion. Some of the key topics explored in this article include:

• CAMP Companies and Products Dominate
  • Spring SAWC was dominated by companies showcasing their CAMPs, with nearly 30 companies exhibiting this year. The market is currently led by ...
    
• Reimbursement: It’s Complicated
  • Skin substitute utilization is heavily influenced by reimbursement and setting of care. The physician office currently captures the largest share of the skin substitutes market. This is primarily driven by ...
    
• Emerging Sites of Care
  • In its Site of Care module, SmartTRAK currently tracks the use of CTP or CAMP products in the surgical suite, HOPD, physician office, VA Health system and burn center. In discussions at SAWC, SmartTRAK learned ...
• Future Growth
  • Despite reimbursement hurdles, SmartTRAK projects strong growth for this segment in the coming years, primarily due to ...
    

To download and read the complete "SAWC Spring 2023: Spotlight on the Skin Substitute Market" market perspective article by Susan Paquette, SmartTRAK's VP & General Manager, Wound, just click the button below.

Continued strength in ortho robotics placements and a crowd of new product launches in Q123 set the stage for growth in the remainder of the year.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Ortho Enabling Tech Market Recap* are:

• Complete Q123 Otho Enabling Tech Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All US Ortho Enabling Tech Companies' News, Revenues, Data, Charts and Market Shares
• Robust Q123 Robotics Performances by Company
  
  • Stryker
  • Zimmer Biomet
  • Smith+Nephew
  • JNJ/Depuy Synthes
• New Product Introductions
  
  • Robotics and Ecosystem Launches
  • Navigation and Planning Innovations
• SmartTRAK's Selected Highlights from Q123 Conferences
  
  • JP Morgan 41st Annual Healthcare Conference
  • Canaccord Genuity 2023 Musculoskeletal Conference
  • AAOS 2023 Annual Meeting

In an International Society for Technology in Arthroplasty (ISTA) presentation at the American Academy of Orthopaedic Surgeons 2023 (AAOS 2023) Annual Meeting, President, Digital, Robotics and Enabling Technology at SYK Robert Cohen discussed innovations including a fully connected operating room for a common user experience with planning and mixed-reality guidance combined with robotics and data transfer capabilities. Enabling technology continues to see adoption and integration in orthopedics and with it, the introduction of ...

Read the entire Q123 Ortho Enabling Tech Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

Biologics had a whopping quarter, Advanced Dressings saw strong gains and External Devices continue to show minimal gains due to traditional NPWT holding down the segment.

The global AWC market is split geographically, with the US accounting for just over half, followed by Europe and then ROW, due to the US using higher technology products and their allowed reimbursement. SmartTRAK has noted shifts in market share, largely driven by currency movements. In Q123, there was less of an impact. From Q221 to Q123, the US went from 52.6% share to 53.1%, Europe from 27.9% to 28.6% and ROW from 19.5% to 18.2%.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Advanced Wound Care Market Recap* are:

• Complete Q123 Advanced Wound Care Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All AWC Companies' News, Revenues, Data, Charts and Market Shares
• WW Advanced Dressings: Acceleration of Continued Solid Growth
• Biologics: An Impressive Quarter
  
  • Skin Substitutes/CTPs
  • Topical Delivery/Drug
  • Collagen/Active Dressings
• External Devices: Single-use NPWT and Topical Oxygen Therapy Drive Growth
• Growth Analysis – Currency Having a Less Strong Impact
  • Growth Details for Key Companies in Q123
• Other Notable Q123 AWC Events

3M remained the global revenue leader in the Q123 WW AWC market, with Smith+Nephew (SNN) is in second place and Mölnlycke rounding out the top three,  with revenues of ...

Read the entire Q123 AWC Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

New SaaS technology offering delivers competitive advantage in rapidly changing Ambulatory Surgery Center market.

SmartTRAK, the leading global Medtech business and market software intelligence solution in the Orthopedics, Wound Care, Regenerative Medicine and Neuro Therapy markets, is pleased to announce the release of ASC Insights, the industry’s first-ever commercially available platform-based solution for the growing Ambulatory Surgery Center (ASC) market. ASC Insights provides real-time insights and rich data to help clients better understand market trends and accelerate commercial growth strategies.

In recent years, the Orthopedic ASC market, valued at over $10 billion, has undergone a significant transition as surgeries increasingly shift from traditional inpatient settings to outpatient ASCs. This shift necessitates that Medtech companies explore new ways to stay informed about myriad data sources and market shifts to drive their commercial growth strategies.

The ASC Insights offering is an extension of the SmartTRAK platform, encompassing comprehensive market analyses and proprietary qualitative insights on trends, as well as readily extractable quantitative metrics. Alternatively, enterprise customers can seamlessly integrate these metrics into their business intelligence platforms. Subscribers to SmartTRAK ASC Insights gain access to a historical news archive, recaps of changes in key facility ownership and information on technologies and reimbursement. Furthermore, customers receive valuable Daily Updates, ensuring up-to-date and timely coverage of noteworthy ASC industry developments. They also enjoy on-demand, direct access to SmartTRAK expert analysts.

New products and technologies in Shoulder Replacement and the Extremities Fixation Segments planted the seeds for sequential growth in the Q123 Extremities Market

The US Extremities Market grew 7.8% in Q123 with new products and continued recovery of elective procedures encouraging growth despite concerns about a looming recession. While headwinds such as supply chain constraints, economic challenges and staffing shortages could darken the forecast, SmartTRAK expects the Extremities Market to weather these issues and continue to experience strong growth through 2023.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Extremities Market Recap* are:

• Complete Q123 Extremities Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• New Products and Technologies That are Planting the Seeds for Growth in Shoulders
• Extremities Fixation Closes the Quarter on High with Solid Returns
• Q123 Regulatory Highlights

Both US Extremities Fixation subsegments, Upper Extremities Fixation and Foot Ankle Fixation, ended the first quarter of 2023 with ...

Read the entire Q123 Extremities Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.

The success or failure of medical technology often hinges on dynamics occurring within healthcare policy and reimbursement. In this article, SmartTRAK highlights policy and reimbursement themes from SAWC Spring 2023

SAWC Spring 2023 welcomed clinicians, researchers and industry to Washington, DC, to share knowledge and network on the latest developments in advanced wound care. While the attention centered on advances in disease management and technological innovation, SmartTRAK noted compelling discussions involving healthcare policy and reimbursement that may have been missed by some industry participants.

In this article, which can be downloaded here, SmartTRAK explores coverage and payment dynamics surrounding the following topics:

• Artificial Intelligence: Implications for Advanced Wound Care
  • Artificial Intelligence (AI) is the hot topic of the day. Companies seek to capitalize on it, governments want to regulate it, some workers fear it ...
    
• Medicare Advantage: Growing Concerns About Claims Denials
  • Medicare Advantage plans are under fire for reportedly restricting access to medically necessary care ...
    
• Topical Oxygen Therapy: Reconsidering Local MAC Coverage Policy
  • In 2017, industry stakeholders requested that CMS remove the non-coverage of topical oxygen therapies (TOT) from the National Coverage Determination (NCD) Manual ...
    

Artificial Intelligence (AI) is the hot topic of the day. Companies seek to capitalize on it, governments want to regulate it and some workers fear it. Given the attention, it is fitting that sessions touching on AI bookended SAWC Spring 2023. Daniel Kraft, MD, opened the keynote address with captivating slides on how medicine is positioned within the fourth industrial revolution, where robotics, big data and AI are transforming care and leading to ...

To download and read the complete "Underlying Dynamics in Healthcare Policy and Reimbursement" by Terry Hayslett, Senior Analyst, Advanced Wound Care, just click the button below.

Among the many topics covered in detail in SmartTRAK's comprehensive Q123 Total Joints Market Recap* are:

• Complete Q123 Total Joints Market Overview
• SmartTRAK's Expert Market Analysis and Insights
• All Company News, Revenues, Data, Charts and Shares
• Technologies and Procedure Recovery Elevating Hip Growth
• The Ongoing March Towards Cementless Knees
• Deals and Financing Highlights
• Q123 Regulatory Highlights

Will this momentum continue throughout 2023? SmartTRAK believes underlying demand for hip and knee replacement surgery will ...

Read the entire Q123 Total Joints Market Recap, including SmartTRAK's expert analysis, news, data, charts, company revenues and shares*

*These links and the complete unedited article can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.